Trial NCT02513667

View at ClinicalTrials.gov 
Org. Study IDs: STU 042015-076

Last trial update was posted on 2023-02-03

MeSH Interventions

Ceritinib

MeSH Conditions

Adenocarcinoma Adenocarcinoma of Lung

Other Conditions

ALK-positive Non-small Cell Lung Cancer

Stopping Reasons

The study was terminated after UTSW was informed by Novartis that further support for the study would not be provided

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID